Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-017305

Chief Business Development Off sold 6,771 shares at an average $57.62 ($390,143)

  • Chief Business Development Off acquired 6,771 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BENZENO SHARON · Chief Business Development Off

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-01 Exercise or conversion : show line 1 in the form +2,604 $6.55 $17,056 2,604 D
2021-03-01 Exercise or conversion : show line 2 in the form +2,604 $6.55 $17,056 5,208 D
2021-03-01 Exercise or conversion : show line 3 in the form +1,563 $7.27 $11,363 6,771 D
2021-03-01 Sale : show line 4 in the form −6,210 $57.57 $357,510 561 D
2021-03-01 Sale : show line 5 in the form −561 $58.17 $32,633 0 D
Open-market sales · 6,771 sh · avg $57.62 · $390,143

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2021-03-01 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −2,604 20,834 D
2021-03-01 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −2,604 49,480 D
2021-03-01 Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) −1,563 34,375 D
Loading xslF345X03/doc4.xml…